PANDEIA THERAPEUTICS LIMITED - CAMBRIDGE
| Company Profile | Company Filings |
Overview
PANDEIA THERAPEUTICS LIMITED is a Private Limited Company from CAMBRIDGE UNITED KINGDOM and has the status: Active.
PANDEIA THERAPEUTICS LIMITED was incorporated 5 years ago on 13/07/2018 and has the registered number: 11463856. The accounts status is SMALL and accounts are next due on 30/09/2024.
PANDEIA THERAPEUTICS LIMITED was incorporated 5 years ago on 13/07/2018 and has the registered number: 11463856. The accounts status is SMALL and accounts are next due on 30/09/2024.
PANDEIA THERAPEUTICS LIMITED - CAMBRIDGE
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
| Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
|---|---|---|
| 31 / 12 | 31/08/2022 | 30/09/2024 |
Registered Office
C/O THE CAMBRIDGE PARTNERSHIP LTD, THE DOROTHY HODGKIN BUILDING
CAMBRIDGE
CB22 3FH
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
| Last Statement | Next Statement Due |
|---|---|
| 26/06/2023 | 10/07/2024 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
| Name | Born | Nationality | Role | Appointed | Status |
|---|---|---|---|---|---|
| THE CAMBRIDGE PARTNERSHIP LIMITED | Corporate Secretary | 2019-08-09 | CURRENT | ||
| AUSTIN KIM | Dec 1963 | American | Director | 2022-12-22 | CURRENT |
| MR TIMOTHY SCHULZ-UTERMOEHL | Oct 1972 | German | Director | 2018-07-13 UNTIL 2019-07-30 | RESIGNED |
| DR MARTIN QUIBELL | Jul 1966 | British | Director | 2019-03-05 UNTIL 2019-09-19 | RESIGNED |
| DR FRASER MURRAY | May 1971 | British | Director | 2019-03-05 UNTIL 2022-12-22 | RESIGNED |
| DAVID JOHN GRAINGER | Oct 1966 | British | Director | 2019-09-19 UNTIL 2022-12-22 | RESIGNED |
| MR FRANCESCO DE RUBERTIS | Jan 1970 | Italian | Director | 2019-09-19 UNTIL 2022-12-22 | RESIGNED |
Persons with Significant Control
| Name | Active from | Born | Address | Level of control |
|---|---|---|---|---|
| Acadia Pharmaceuticals Inc. | 2022-12-22 | San Diego Ca 92130-2976 | Ownership of shares 75 to 100 percent | |
| Medicxi Ventures I Lp | 2019-09-20 - 2022-12-22 | Jersey | Ownership of shares 75 to 100 percent | |
| Dr Martin Quibell | 2019-03-05 - 2019-03-05 | 7/1966 | Cambridge |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent Right to appoint and remove directors |
| Dr Fraser Murray | 2019-03-05 - 2019-03-05 | 5/1971 | Cambridge |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent Right to appoint and remove directors |
| Dr Timothy Schulz-Utermoehl | 2018-07-13 - 2019-09-20 | 10/1972 | Cambridge |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Free Reports Available
| Report | Date Filed | Date of Report | Assets |
|---|---|---|---|
| Pandeia Therapeutics Limited - Accounts to registrar (filleted) - small 18.2 | 2022-10-06 | 31-08-2022 | £796,269 Cash £829,602 equity |
| Pandeia Therapeutics Limited - Accounts to registrar (filleted) - small 18.2 | 2022-03-25 | 31-12-2021 | £1,525,884 Cash £1,629,832 equity |
| Pandeia Therapeutics Limited - Accounts to registrar (filleted) - small 18.2 | 2021-02-17 | 31-12-2020 | £364,357 Cash £745,078 equity |
| Pandeia Therapeutics Limited - Accounts to registrar (filleted) - small 18.2 | 2020-03-31 | 31-12-2019 | £1,385,926 Cash £1,406,729 equity |